ストックスクリーナーアプリを入手
6.57
6.41%
-0.45
アフターアワーズ：
6.52
-0.05
-0.76%
前日終値:
$7.02
開ける：
$6.76
24時間の取引高:
520.03K
Relative Volume:
0.13
時価総額：
$54.85M
収益：
-
当期純損益:
$-7.82M
株価収益率:
-5.7305
EPS:
-1.1465
ネットキャッシュフロー:
$-8.00M
1週間 パフォーマンス:
-14.56%
1か月 パフォーマンス:
+383.09%
6か月 パフォーマンス:
+169.26%
1年 パフォーマンス:
+163.86%
1日の値動き範囲:
$6.12
$6.95
1週間の範囲:
$6.12
$9.37
52週間の値動き範囲:
$0.72
$9.37
Edesa Biotech Inc Stock (EDSA) Company Profile
Compare EDSA vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
6.57 | 58.60M | 0 | -7.82M | -8.00M | -1.1465 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Edesa Biotech Inc (EDSA) 最新ニュース
Gainers Report: Can Edesa Biotech Inc be the next market leader2026 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn
If You Invested $1,000 in Edesa Biotech Inc (EDSA) - Stock Titan
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Edesa Biotech Inc - GuruFocus
Volume Recap: Will Edesa Biotech Inc announce a stock split2026 Top Gainers & Weekly High Return Forecasts - baoquankhu1.vn
Bull Bear: Will Edesa Biotech Inc announce a stock splitPortfolio Gains Report & Daily Growth Stock Tips - baoquankhu1.vn
Perceptive Advisors stake: 563,239 shares in EDESA (NASDAQ: EDSA) - Stock Titan
EDSA SEC FilingsEdesa Biotech Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Edesa Biotech (EDSA) president buys 2,000 shares in open market - Stock Titan
Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Expands By 9,253.7% - MarketBeat
Edesa Biotech (EDSA) CEO adds 1,000 shares in open-market buy - Stock Titan
Best Biotech Stocks To Follow Today – March 7th - Defense World
Edesa Biotech’s Paridiprubart Trial Success Spurs Market Optimism - StocksToTrade
Edesa Biotech Gains Ground with Positive Clinical and Financial News - timothysykes.com
Will Edesa Biotech Inc. stock attract more institutional investorsPortfolio Performance Report & Weekly Return Optimization Plans - Naître et grandir
Best Biotech Stocks To Follow TodayMarch 7th - MarketBeat
Edesa Biotech Surges Following Promising Clinical Data in ARDS Treatment - StocksToTrade
Edesa Biotech Advances on Promising Drug Trial Results - timothysykes.com
Velan Capital Investment Management LP Increases Stake in Edesa Biotech Inc - GuruFocus
Edesa Biotech reports FQ1 net loss of $2.2 million - MSN
Price Action: Will Edesa Biotech Inc announce a stock splitJuly 2025 Earnings & High Yield Equity Trading Tips - baoquankhu1.vn
Edesa Biotech (NASDAQ:EDSA) CEO Pardeep Nijhawan Acquires 10,000 Shares - MarketBeat
Edesa Biotech (EDSA) CEO-linked entity adds 10,000 shares in open-market buy - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Aug Mood: Can Edesa Biotech Inc be the next market leaderWatch List & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Edesa Biotech (EDSA) CEO-linked entity acquires 10,000 common shares - Stock Titan
FY2026 EPS Forecast for Edesa Biotech Decreased by Analyst - Defense World
CEO-linked entity buys 10,000 Edesa Biotech (EDSA) shares - Stock Titan
Edesa Biotech (NASDAQ: EDSA) CEO adds 3,000 shares in open-market purchases - Stock Titan
Point72 group (NASDAQ: EDSA) reports 600,000 shares, 7.2% stake - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Velan Capital details Edesa Biotech (NASDAQ: EDSA) 9.99% stake - Stock Titan
Nijhawan group boosts Edesa Biotech (EDSA) stake to 19.99% in 13D/A - Stock Titan
Edesa Biotech (NASDAQ: EDSA) CEO adds 50,571 shares in open-market buys - Stock Titan
[Form 4] Edesa Biotech, Inc. Insider Trading Activity - Stock Titan
EDSA: Strengthened Phase 3 ARDS Data Shows Significant Reduction in 28-Day Mortality - Research Tree
Edesa Biotech CEO Makes Bold Insider Move With Fresh Share Purchase - TipRanks
Edesa Biotech Advances with Promising Phase 3 Outcomes - StocksToTrade
Edesa Biotech’s Paridiprubart Phase 3 Success Drives Optimism - timothysykes.com
Edesa Biotech’s Strategic Advances Boost Stock Outlook - StocksToTrade
Edesa Biotech Surpasses Expectations with Promising Phase 3 Data - timothysykes.com
EDSA Technical Analysis & ETF Price Forecast - Intellectia AI
Why Is Edesa Biotech, Inc. (EDSA) Stock Up Today? - Meyka
Why Did EDSA Stock Rally More Than 70% Today? - Asianet Newsable
Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study - Investorideas.com
Edesa Biotech stock surges on positive Phase 3 trial data By Investing.com - Investing.com Canada
Edesa Biotech stock surges on positive Phase 3 trial data - Investing.com
Edesa Biotech reports mortality reduction in phase 3 trial By Investing.com - Investing.com Australia
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results - TipRanks
Edesa Biotech reports mortality reduction in phase 3 trial - Investing.com
Edesa Biotech reports additional results from phase 3 paridiprubart study - marketscreener.com
Edesa Biotech Inc (EDSA) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):